Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Pharmacogenomics and Personalized Medicine|August 25, 2021
The Value of Population Screening in Advancing Personalized Medicine in the Field of Lung CancerAlice Mogenet, Laurent Greillier, Pascale TomasiniBulletin Du Cancer|March 28, 2025
[Recommendations for the management of oligometatic NSCLC]Alice Mogenet, Laurent Greillier, Pascale TomasiniBulletin Du Cancer|September 26, 2020
[Predictable toxicities with futures immunotherapies or combinations]Alice Mogenet, Pascale Tomasini, Laurent Greillier, et al.Clinical & Experimental Metastasis|December 20, 2023
Computational markers for personalized prediction of outcomes in non-small cell lung cancer patients with brain metastasesSébastien Benzekry, Pirmin Schlicke, Alice Mogenet, et al.CPT: Pharmacometrics & Systems Pharmacology|November 27, 2023
Killing a fly with a sledgehammer: Atezolizumab exposure in real-world lung cancer patientsSophie Marolleau, Alice Mogenet, Clara Boeri, et al.Translational Cancer Research|January 16, 2025
IRF5 as a potential immunological biomarker in lung adenocarcinomaSimei Li, Fangling Zhou, Huahong Lan, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 13, 2025
Is adjuvant chemotherapy beneficial in NSCLC patients over 75? Insights from a retrospective analysisYohann Vincent, Faustine Enoch, Vanessa Pauly, et al.Respiratory Medicine and Research|August 25, 2024
Impact of preexisting interstitial lung disease on outcomes of lung cancer surgery: A monocentric retrospective studyAlice Goga, Alex Fourdrain, Paul Habert, et al.Cancers|December 17, 2024
Lack of Prophylactic Cranial Irradiation for Extensive Small-Cell Lung Cancer in Real Life, with the Emergence of ImmunotherapyAlice Daumas, Celestin Bigarre, Mohamed Boucekine, et al.Journal of Translational Medicine|September 19, 2023
Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancerAlice Mogenet, Pascal Finetti, Emilie Denicolai, et al.Pageof 2